ETC
RPRX icon

Exchange Traded Concepts’s Royalty Pharma RPRX Stock Holding History

Exchange Traded Concepts’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-395
Closed -$18.9K – 1638
2026
Q1 		$18.9K Buy
+395
New +$17.3K ﹤0.01% 1491
2023
Q1 		– Sell
-70,618
Closed -$2.79M – 1259
2022
Q4 		$2.79M Buy
+70,618
New +$2.95M 0.08% 165

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Exchange Traded Concepts's RPRX Position: Q2 2026 in Review

Exchange Traded Concepts sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 395 shares — an estimated $18.9K sold.

Exchange Traded Concepts first reported a position in RPRX in Q4 2022 and held it in 2 quarters. The position peaked at $2.79M in Q4 2022. 107 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Exchange Traded Concepts reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • Exchange Traded Concepts sold 395 Royalty Pharma shares in Q2 2026, an estimated $18.9K.
  • Exchange Traded Concepts first reported a position in Royalty Pharma in Q4 2022 and held it in 2 quarters.
  • Exchange Traded Concepts's Royalty Pharma position peaked at $2.79M in Q4 2022.
  • 107 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.